Financhill
Back

Abbott Laboratories Quote, Financials, Valuation and Earnings

Sell
48

ABT
Abbott Laboratories

Last Price:
111.48
Seasonality Move:
3.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Abbott Laboratories Price Quote

$111.48

Abbott Laboratories Key Stats

Sell
48
Abbott Laboratories (ABT) is a Sell

Day range:
$110.44 - $111.53
52-week range:
$101.24 - $142.60
Dividend yield:
1.67%
P/E ratio:
28.29
P/S ratio:
4.35
P/B ratio:
5.35%

Volume:
2.8M
Avg. volume:
4.2M
1-year change:
-9.23%
Market cap:
$195.2B
Revenue:
$43.1B
EPS:
$4.79

How Much Does Abbott Laboratories Make?

Is Abbott Laboratories Growing As A Company?

  • What Is Abbott Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Abbott Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.73%

Abbott Laboratories Stock Price Performance

What Is Abbott Laboratories 52-Week High & Low?

Abbott Laboratories Price To Free Cash Flow

Is It Risky To Buy Abbott Laboratories?

Is Abbott Laboratories Cash Flow Positive?

  • What Is ABT Cash Flow From Operations?
    Cash flow from operations (TTM) is $10.2B
  • What Is Abbott Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$7.9B
  • What Is Abbott Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.9B

Abbott Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    ABT return on invested capital is 16.09%
  • What Is Abbott Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is 11.55%
  • What Is ABT Return On Equity?
    ROE is a measure of profitability and is 24.31%

Abbott Laboratories Earnings Date & Stock Price

Abbott Laboratories Competitors

  • Who Are Abbott Laboratories's Competitors?
    Below is a list of companies who compete with Abbott Laboratories or are related in some way:
    • Becton, Dickinson and Co (BDX)
    • Cardiovascular Systems Inc (CSII)
    • Intuitive Surgical Inc (ISRG)
    • Insulet Corp (PODD)
    • Tandem Diabetes Care Inc (TNDM)

Abbott Laboratories Dividend Yield

Abbott Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: 72.73% 25.29%
Revenue: 10.11% 8.24%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 2
Sell Recommendations: 1
Price Target: 126.09
Upside from Last Price: 13.11%

Major Shareholders

  • How many ABT shares are owned by institutional investors?
    2.3B ABT shares are owned by institutional investors
  • How many ABT shares are owned by insiders?
    15M ABT shares are owned by insiders